ES2091489T3 - Derivados de imidazol y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de imidazol y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2091489T3
ES2091489T3 ES92921391T ES92921391T ES2091489T3 ES 2091489 T3 ES2091489 T3 ES 2091489T3 ES 92921391 T ES92921391 T ES 92921391T ES 92921391 T ES92921391 T ES 92921391T ES 2091489 T3 ES2091489 T3 ES 2091489T3
Authority
ES
Spain
Prior art keywords
contain
pharmaceutical compositions
imidazole
derivatives
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92921391T
Other languages
English (en)
Inventor
Keiko Koh
Mikio Taniguchi
Noriie Itoh
Hiroshi Kushida
Osamu Morita
Hiroyoshi Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2091489T3 publication Critical patent/ES2091489T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA INVENCION SUMINISTRA UN NUEVO DERIVADO DE LA IMIDAZOLA QUE TIENE LA FORMULA QUIMICA I. ESTOS COMPUESTOS SON UTILES PARA PREVENIR O TRATAR LA HIPERTENSION O EL FALLO CARDIACO CONGESTIVO Y TIENEN UNA ALTA ACTIVIDAD, UNA RAPIDA ACCION DESPUES DE SU INYECCION INTRAVENOSA, UNA BUENA ABSORCION ORAL, UNA BAJA TOXICIDAD Y UNA ACCION PROLONGADA EN EL TIEMPO. TAMBIEN SE SUMINISTRAN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS.
ES92921391T 1991-10-24 1992-10-14 Derivados de imidazol y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2091489T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP27753791 1991-10-24
JP32347491 1991-12-07
JP9519192 1992-04-15
JP4216809A JPH06107661A (ja) 1991-10-24 1992-08-14 イミダゾール誘導体およびこれを有効成分とする医薬組成物

Publications (1)

Publication Number Publication Date
ES2091489T3 true ES2091489T3 (es) 1996-11-01

Family

ID=27468309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92921391T Expired - Lifetime ES2091489T3 (es) 1991-10-24 1992-10-14 Derivados de imidazol y composiciones farmaceuticas que los contienen.

Country Status (11)

Country Link
EP (2) EP0540209A1 (es)
JP (2) JPH06107661A (es)
AT (1) ATE140458T1 (es)
AU (1) AU661346B2 (es)
CA (1) CA2118802A1 (es)
DE (1) DE69212331T2 (es)
DK (1) DK0609289T3 (es)
ES (1) ES2091489T3 (es)
GR (1) GR3021143T3 (es)
MX (1) MX9206157A (es)
WO (1) WO1993008193A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06271576A (ja) * 1993-03-19 1994-09-27 Upjohn Co:The イミダゾール誘導体の製法
JPH0710879A (ja) * 1993-06-21 1995-01-13 Upjohn Co:The イミダゾール誘導体の製法
US6005105A (en) * 1993-06-21 1999-12-21 Pharmacia & Upjohn Company Process for producing imidazole derivative
AUPN236595A0 (en) 1995-04-11 1995-05-11 Rescare Limited Monitoring of apneic arousals
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
HUP0203326A3 (en) 1999-08-30 2003-04-28 Sanofi Aventis Deutschland Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250180A (en) * 1979-07-16 1981-02-10 Ortho Pharmaceutical Corporation Method of treating arrhythmia
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
DE3347290A1 (de) * 1983-12-28 1985-07-11 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 2-phenyl-imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
AU2759292A (en) 1993-05-21
WO1993008193A1 (en) 1993-04-29
DE69212331D1 (de) 1996-08-22
GR3021143T3 (en) 1996-12-31
EP0540209A1 (en) 1993-05-05
DK0609289T3 (da) 1996-11-25
CA2118802A1 (en) 1993-04-29
EP0609289B1 (en) 1996-07-17
ATE140458T1 (de) 1996-08-15
JPH06107661A (ja) 1994-04-19
EP0609289A1 (en) 1994-08-10
MX9206157A (es) 1994-05-31
JPH07500336A (ja) 1995-01-12
DE69212331T2 (de) 1997-01-09
AU661346B2 (en) 1995-07-20

Similar Documents

Publication Publication Date Title
FI924397A0 (fi) Substituerade pyrimidiner.
ES2175624T3 (es) Derivados de pirazolo(4,3-d)pirimidina y composiciones farmaceuticas que los contienen.
NO922147D0 (no) Heterocykliske derivater
EP0902007A4 (en) CHALCONE DERIVATIVES AND MEDICINES CONTAINING THEM
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
EP0976748A4 (en) PYRROLIDIN DERIVATIVES HAVING A PHOSPHOLIPASE A2 INHIBITING EFFECT
MX9206157A (es) Derivados de imidazol y composiciones farmaceuticas que contienen a los mismos.
DE69205327D1 (de) Harnstoffderivate, Verfahren zu ihrer Herstellung und diese enthaltende Medikamente.
DK0622361T3 (da) Heterocykliske forbindelser som bradykininantagonister
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
ATE243697T1 (de) Substitutierte heterozyclische derivate als crf antagonisten
FI980341A0 (fi) 2-oksi-indolijohdannaisia
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
DE69108138D1 (de) Imidazopyridinderivate und ihre Verwendung.
DE69122418D1 (de) Arzneimittellösung enhaltend Derivate von FK506
DE69524246D1 (de) 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten
DE69200160D1 (de) Angiotensin-II-Antagonisten.
DK0412940T3 (da) Hydantoin eller imidazolidintrionderivater til forebyggelse eller behandling af nyresvigt.
ATE121621T1 (de) Verwendung von tetrahydrothienopyridinderivate als angiogenese-inhibitoren.
NO961236L (no) Pyrrolodiazin-derivater som stabilisatorer for klorholdige polymerisater
DK360388A (da) Laegemiddel til behandling af hjerteinsufficiens
OA07703A (fr) Polyméthylène imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
IL92646A0 (en) Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
ITMI920082A1 (it) Derivati solforati di acidi biliari

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 609289

Country of ref document: ES